CSVAX | VIHAX | CSVAX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 9 years | - |
Gain YTD | 6.452 | 6.366 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 536M | 8.54B | 6% |
Annual Yield % from dividends | 2.21 | 4.87 | 45% |
Returns for 1 year | 2.64 | 8.51 | 31% |
Returns for 3 years | 7.12 | 8.69 | 82% |
Returns for 5 years | 13.46 | 23.63 | 57% |
Returns for 10 years | 21.82 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MADFX | 34.66 | -0.17 | -0.49% |
Matrix Advisors Dividend | |||
IJEAX | 12.12 | -0.07 | -0.57% |
VY® JPMorgan Emerging Markets Equity A | |||
ERASX | 40.82 | -0.57 | -1.38% |
Eaton Vance Atlanta Capital SMID-Cap R6 | |||
SDGCX | 85.20 | -2.10 | -2.41% |
DWS Capital Growth C | |||
BGEIX | 14.55 | -0.51 | -3.39% |
American Century Global Gold Inv |